[{"AccountsPayableCurrent_0_Q1_USD":1187000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q1_shares":3810953.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":4125000.0,"AmortizationOfFinancingCosts_1_Q1_USD":199000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":563000.0,"ProceedsFromIssuanceOfLongTermDebt_1_Q1_USD":25000000.0,"InvestmentIncomeInterest_1_Q1_USD":878000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":52000.0,"InterestExpenseRelatedParty_1_Q1_USD":0.0,"IncreaseDecreaseInInterestPayableNet_1_Q1_USD":81000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":641000.0,"AccountsPayableRelatedPartiesCurrent_0_Q1_USD":112000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":8000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":22273000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":134227.0,"OtherAssetsNoncurrent_0_Q1_USD":381000.0,"NonoperatingIncomeExpense_1_Q1_USD":234000.0,"LongTermDebt_0_Q1_USD":45913000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":9000000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":20000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":34.39,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":485253000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":11.31,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":563000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":12907000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":939000.0,"OperatingLeasePayments_1_Q1_USD":300000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":606000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":148000.0,"OperatingLeaseLiability_0_Q1_USD":754000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":150000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":110000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":171000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":256672000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":176000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":186000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":80000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":904000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":200000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":181000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":1534755.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-1000.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":-95000.0,"ProfitLoss_1_Q1_USD":-20141000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":5155000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":676000.0,"NetIncomeLoss_1_Q1_USD":-20141000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-11417000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-676000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":25000000.0,"LiabilitiesCurrent_0_Q1_USD":4576000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":263915000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":768000.0,"Liabilities_0_Q1_USD":55220000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4510000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.62,"Depreciation_1_Q1_USD":52000.0,"CommonStockValue_0_Q1_USD":2000.0,"CommonStockSharesOutstanding_0_Q1_shares":25153553.0,"CommonStockSharesIssued_0_Q1_shares":28964506.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":256672000.0,"AssetsCurrent_0_Q1_USD":261827000.0,"Assets_0_Q1_USD":263915000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-6680000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-276560000.0,"StockholdersEquity_0_Q1_USD":208695000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":32470402.0,"DebtInstrumentUnamortizedDiscount_0_Q1_USD":4087000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":13423199.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":370000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":828000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":1492000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":60000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0119,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.6263,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensation_1_Q1_USD":563000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":15865000.0,"OperatingIncomeLoss_1_Q1_USD":-20375000.0,"OperatingExpenses_1_Q1_USD":20375000.0,"InterestPayableCurrent_0_Q1_USD":237000.0,"InterestPaidNet_1_Q1_USD":458000.0,"InterestExpense_1_Q1_USD":738000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":50000000.0,"CommonStockSharesAuthorized_0_Q1_shares":400000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":3004000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0725,"PropertyPlantAndEquipmentDisposals_1_Q1_USD":0.0,"Ticker":"PHAT","CIK":"1783183","name":"PHATHOM PHARMACEUTICALS, INC.","OfficialName":"Phathom Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"562637189.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200512"}]